Pediatric super-refractory status epilepticus treated with allopregnanolone. - Wikidata - awgldk - TriplyDB

Pediatric super-refractory status epilepticus treated with allopregnanolone.

Pediatric super-refractory status epilepticus treated with allopregnanolone.

http://www.wikidata.org/entity/Q34445859

about

Management of Status Epilepticus in Children Status Epilepticus.First-in-man allopregnanolone use in super-refractory status epilepticus.Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency.Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.Neurosteroid Deficiency Associated With Epilepsy.Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome.Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.Pharmacologic treatment of status epilepticus.Super-Refractory Status Epilepticus: A Therapeutic Challenge in Paediatrics.Brexanolone as adjunctive therapy in super-refractory status epilepticus.Decreased allopregnanolone levels in cerebrospinal fluid obtained during status epilepticus.A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?An update on the recognition and treatment of non-convulsive status epilepticus in the intensive care unit.Brain activity patterns in high-throughput electrophysiology screen predict both drug efficacies and side effects.Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies.Updates in Refractory Status Epilepticus.

P2860

Q26752721-D8323E53-DB57-4953-8DF4-DADE73783202 Q30277237-384B24CE-5C09-4728-8182-E0936C8387E3 Q33753851-BB84F900-6BDE-4728-9382-CC09A528FB5C Q34482877-17620867-972C-4B05-93A6-A29BEAB982D0 Q36626032-52265FA1-6F96-4D42-B606-CA5BFF11567C Q36771157-A78A2067-17E5-4BC4-BAEA-57EFAB1C7E1C Q38373996-ED46A594-7471-4C46-ABE8-A4A3EBBAA0BB Q38646868-67137584-1A25-4E74-A08D-8FDB0DE7B8C4 Q38656719-88AEDB30-62B2-4B3A-AB78-D6936F3635C1 Q41874312-5F2F72E6-BE7F-4D4D-8641-727539886417 Q42702432-32905C50-55C2-404F-B544-DF50DE54CB18 Q47360500-08BFA4B1-404F-4137-84BB-7C7D83C00938 Q47548600-C5184ABA-795B-4A7E-83DF-5ADEAAD9D988 Q47731492-0050D90B-7FB4-4DA8-848A-1DB62C1481ED Q47863623-86C7DF22-E1AD-4E84-9FB4-F7747536D459 Q48129765-E13F20F8-06B6-43F7-9448-440F79BE39FA Q54943200-FB37D3AA-D5BC-4A1C-B093-8CFDD8E219D7

P2860

Pediatric super-refractory status epilepticus treated with allopregnanolone.

http://www.wikidata.org/entity/Q34445859

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@ast

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@en

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@nl

type

label

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@ast

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@en

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@nl

prefLabel

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@ast

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@en

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@nl

P1433

Q34445859-D586FE6C-E925-4999-BB0D-B0099735B060

P1476

Q34445859-798F0BC3-A14C-4A6E-8EE8-A147C238B992

P2093

Q34445859-01B18A6D-11B9-41E1-AEAA-18A754A75700

Q34445859-1DFE81B6-12BF-4932-B40A-2B0297D8269F

Q34445859-21007344-303D-4FAC-B235-22075E13270B

Q34445859-33C95F0F-E8AB-44A2-BB74-1D819434E5C5

Q34445859-520C64EB-EA2F-4D68-821F-29F4FD0A161B

Q34445859-5B2D17E7-B3E0-45D0-AAC2-15B525294826

Q34445859-AA138B93-2943-4E5C-9637-14BDA29A4F5C

Q34445859-D8769929-F7C7-4FE5-BDA8-6DCAF2FCAE93

Q34445859-DD66B961-7303-4CCD-9BF4-044C3AD42E60

P2860

Q34445859-04C8391C-FD38-484F-8A2C-38147CD47855

Q34445859-279D294E-2B0A-4A0F-863A-FE4D8BA9678A

Q34445859-28970230-63A8-41F2-BD3A-B71EAEE87CEF

Q34445859-57780285-8EFA-42E9-BCB0-7A34C755FFFE

Q34445859-57AA2B17-62FB-4057-9FA4-6BA4E8E3B410

Q34445859-709FB3E3-E276-4C13-B5C2-84E3FBA88C7D

Q34445859-7638CBCF-A5F7-4600-9653-EA9847274CEA

Q34445859-7B0E10F6-648C-4E10-92AD-CA36799ED36D

Q34445859-B2DDF7DA-7811-407C-9738-9F191A4B4D48

Q34445859-B80123D1-6089-4781-BBE8-D2969DA28677

P304

Q34445859-7038E20C-0A76-4170-B865-A0ECE387ECBA

P31

Q34445859-98FBBB6F-A94B-47CC-B38C-8D0E0C943A08

P356

Q34445859-1066CF87-1443-48B2-BFA2-2EDDABD5DAC4

P433

Q34445859-96A30E07-8673-4CC4-8F44-AEAB9C13D3C3

P478

Q34445859-0B57E867-107E-4EB4-9F4E-A6F3C78CE6F3

P577

Q34445859-C660C94A-01C4-47A7-BB38-1F4CA0BAFC29

P5875

Q34445859-55EF91D8-BDE7-4C6D-BC3F-76C93F7A61F6

P698

Q34445859-9D63ADD2-2E8A-48A7-B84D-B6C7C3A0AC3C

P921

Q34445859-A717D998-11A5-4BE7-A33C-B9E1B729B929

P932

Q34445859-95C90A7D-9D4D-4985-8D88-3867BBEB93D4

P356

P1433

Annals of Neurology

P1476

Pediatric super-refractory status epilepticus treated with allopregnanolone.

@en

P2093

Celia Chang

http://www.w3.org/2001/XMLSchema#string

Craig M Smith

http://www.w3.org/2001/XMLSchema#string

Eileen Broomall

http://www.w3.org/2001/XMLSchema#string

JoAnne E Natale

http://www.w3.org/2001/XMLSchema#string

Joshua Goldstein

http://www.w3.org/2001/XMLSchema#string

Mark S Wainwright

http://www.w3.org/2001/XMLSchema#string

Michael A Rogawski

http://www.w3.org/2001/XMLSchema#string

Michele Grimason

http://www.w3.org/2001/XMLSchema#string

Stephen Kanes

http://www.w3.org/2001/XMLSchema#string

P2860

Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)

The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol

Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation.

Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

Neuroactive steroids for the treatment of status epilepticus

The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy.

Refractory status epilepticus: new insights in presentation, treatment, and outcome.

Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice.

Treatment of status epilepticus: an international survey of experts.

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

P304

911-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24295

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267634516

http://www.w3.org/2001/XMLSchema#string

P698

25363147

http://www.w3.org/2001/XMLSchema#string

P921

status epilepticus

P932

4534165

http://www.w3.org/2001/XMLSchema#string